2,5-dihydroxybenzoic acid has been researched along with niacinamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahangarpour, A; Khorsandi, L; Mard, SA; Noei Razliqi, R | 1 |
| Ahangarpour, A; Khorsandi, L; Mard, SA; Razliqi, RN | 1 |
2 other study(ies) available for 2,5-dihydroxybenzoic acid and niacinamide
| Article | Year |
|---|---|
Gentisic acid protects against diabetic nephropathy in Nicotinamide-Streptozotocin administered male mice by attenuating oxidative stress and inflammation: The role of miR-200a/Keap1/Nrf2 pathway, renin-angiotensin system (RAS) and NF-кB.
Topics: Angiotensins; Animals; Anti-Inflammatory Agents; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Inflammation; Kelch-Like ECH-Associated Protein 1; Kidney; Male; Mice; MicroRNAs; NF-E2-Related Factor 2; NF-kappa B; Niacinamide; Oxidative Stress; Renin-Angiotensin System; Streptozocin | 2023 |
Gentisic acid ameliorates type 2 diabetes induced by Nicotinamide-Streptozotocin in male mice by attenuating pancreatic oxidative stress and inflammation through modulation of Nrf2 and NF-кB pathways.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Inflammation; Kelch-Like ECH-Associated Protein 1; Male; Mice; MicroRNAs; NF-E2-Related Factor 2; NF-kappa B; Niacinamide; Oxidative Stress; Streptozocin | 2023 |